CD274 and neoplasm: The BPSP multi-overcoming immune escape by simultaneously reducing ECM, inhibiting tumor angiogenesis and black PD-1/PD-L1 recognition, and finally converting 'cold' tumors into 'hot' ones and photothermal/chemical/immune killing tumor cells (Scheme 1b).